MENS (Jyong Biotech Ltd. Ordinary Shares) Stock Analysis - Analyst Ratings

Jyong Biotech Ltd. Ordinary Shares (MENS) is a publicly traded Healthcare sector company. As of May 21, 2026, MENS trades at $2.09 with a market cap of $144.76M and a P/E ratio of 0.00. MENS moved -4.13% today. Year to date, MENS is -38.00%; over the trailing twelve months it is flat. Its 52-week range spans $1.43 to $67.00. Rallies surfaces MENS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate MENS?

The average price target is $0.00.

MENS Key Metrics

Key financial metrics for MENS
MetricValue
Price$2.09
Market Cap$144.76M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$67.00
52-Week Low$1.43
Volume1
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

MENS Analyst Consensus

MENS analyst coverage data. Average price target: $0.00.

Latest MENS News

Common questions about MENS

What do analysts rate MENS?
The average price target is $0.00.
Does Rallies show MENS price targets?
Yes. Rallies tracks MENS analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is MENS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for MENS. It does not provide personalized investment advice.
MENS

MENS